Provided by Tiger Trade Technology Pte. Ltd.

Cytosorbents

5.78
-0.2804-4.63%
Volume:2K
Turnover:9.68K
Market Cap:18.15M
PE:-1.00
High:6.11
Open:6.03
Low:5.56
Close:6.06
52wk High:20.40
52wk Low:5.13
Shares:3.14M
Float Shares:2.63M
Volume Ratio:0.22
T/O Rate:0.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8019
EPS(LYR):-2.6347
ROE:-336.21%
ROA:-17.12%
PB:-24.17
PE(LYR):-2.19

Loading ...

CytoSorbents to Present at H.C. Wainwright Global Investment Conference

Reuters
·
Sep 10

CytoSorbents CEO Phillip P. Chan Buys 200,000 Common Shares for USD 70,000

Reuters
·
Sep 10

CytoSorbents trading halted, news pending

TIPRANKS
·
Sep 05

CytoSorbents Effects 1-for-20 Reverse Stock Split to Lift NASDAQ Bid Price Above $1

Reuters
·
Sep 03

Cytosorbents Announces Reverse Stock Split

THOMSON REUTERS
·
Sep 03

CytoSorbents announces real-world data using CytoSorb

TIPRANKS
·
Sep 02

CytoSorbents Says Real-World Analysis Shows 37% Drop in Severe Bleeding with CytoSorb in Urgent CABG Patients on Ticagrelor

Reuters
·
Sep 02

Cytosorbents Announces New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using Cytosorb in Cabg Patients on Ticagrelor and Updates Recent Drugsorb-Atr FDA Pre-Submission Meetings

THOMSON REUTERS
·
Sep 02

Cytosorbents Corp - Cytosorb Use Associated with 37% Relative Reduction in Severe Bleeding in Cabg Patients

THOMSON REUTERS
·
Sep 02

Cytosorbents Corp - Findings to Support New U.S. FDA De Novo Submission for Drugsorb-Atr

THOMSON REUTERS
·
Sep 02

CytoSorbents Releases Investor Presentation on Blood Purification Devices for ICU, Cardiac Surgery Use

Reuters
·
Aug 19

CytoSorbents Holds Annual Shareholder Meeting

Reuters
·
Aug 15

CytoSorbents Posts Investor Presentation Outlining Q2 Revenue, Cash Burn Progress Toward Breakeven

Reuters
·
Aug 12

Cytosorbents Advances Toward Operating Cash Flow Breakeven

TIPRANKS
·
Aug 08

Canada's Spectral Medical Q2 Revenue Falls on Lower Reagent Sales

Reuters
·
Aug 07

Cytosorbents Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

CytoSorbents Q2 FY26 Operating Loss Narrows 27% to $2.6 Million; Revenue Rises 0.2% to $9.6 Million

Reuters
·
Aug 07

CytoSorbents Q2 Adjusted Loss Narrows on Cost Controls

Reuters
·
Aug 07

CytoSorbents Q2 Revenue USD 9.633 Million

Reuters
·
Aug 07

Cytosorbents Q2 Gross Margin 73%

THOMSON REUTERS
·
Aug 07